Addition of Rituximab to BEACOPP(escalated) to improve the outcome of early interim PET positive advanced stage Hodgkin lymphoma patients: second planned interim analysis of the HD18 study
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) Konferenzschrift |
| Sprache: | Englisch |
| Veröffentlicht: |
2014
|
| In: |
Blood
Year: 2014, Jahrgang: 124, Heft: 21 |
| ISSN: | 1528-0020 |
| Schlagworte: | |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0006497119694395
|
| Verfasserangaben: | Peter Borchmann, Heinz Haverkamp, Andreas Lohri, Stefanie Kreissl, Richard Greil, Jana Markova, Michaela Feuring-Buske, Julia Meissner, Ulrich Dührsen, Nicole Engel, Ulrich Keller, Georg Maschmeyer, Markus Dietlein, Carsten Kobe, Michael Fuchs, Volker Diehl, Andreas Engert |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1504678710 | ||
| 003 | DE-627 | ||
| 005 | 20241002094140.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 150630s2014 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)1504678710 | ||
| 035 | |a (DE-576)434678716 | ||
| 035 | |a (DE-599)BSZ434678716 | ||
| 035 | |a (OCoLC)1340696688 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 245 | 0 | 0 | |a Addition of Rituximab to BEACOPP(escalated) to improve the outcome of early interim PET positive advanced stage Hodgkin lymphoma patients |b second planned interim analysis of the HD18 study |c Peter Borchmann, Heinz Haverkamp, Andreas Lohri, Stefanie Kreissl, Richard Greil, Jana Markova, Michaela Feuring-Buske, Julia Meissner, Ulrich Dührsen, Nicole Engel, Ulrich Keller, Georg Maschmeyer, Markus Dietlein, Carsten Kobe, Michael Fuchs, Volker Diehl, Andreas Engert |
| 264 | 1 | |c 2014 | |
| 300 | |a 1 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am30.06.2015 | ||
| 655 | 7 | |a Konferenzschrift |0 (DE-588)1071861417 |0 (DE-627)826484824 |0 (DE-576)433375485 |2 gnd-content | |
| 700 | 1 | |a Borchmann, Peter |0 (DE-588)107278842X |0 (DE-627)82823762X |0 (DE-576)434245321 |4 oth | |
| 700 | 1 | |a Meißner, Julia |0 (DE-588)1236765966 |0 (DE-627)176254850X |4 oth | |
| 773 | 0 | 8 | |i In |t Blood |d Washington, DC : American Society of Hematology, 1946 |g 124(2014,21) Artikel-Nr. 74038, 1 S. |h Online-Ressource |w (DE-627)266886647 |w (DE-600)1468538-3 |w (DE-576)075961938 |x 1528-0020 |7 nnas |a Addition of Rituximab to BEACOPP(escalated) to improve the outcome of early interim PET positive advanced stage Hodgkin lymphoma patients second planned interim analysis of the HD18 study |
| 773 | 1 | 8 | |g volume:124 |g year:2014 |g number:21 |g extent:1 |a Addition of Rituximab to BEACOPP(escalated) to improve the outcome of early interim PET positive advanced stage Hodgkin lymphoma patients second planned interim analysis of the HD18 study |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0006497119694395 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20150630 | ||
| 993 | |a ConferencePaper | ||
| 994 | |a 2014 | ||
| 998 | |g 1236765966 |a Meißner, Julia |m 1236765966:Meißner, Julia |d 910000 |d 910100 |e 910000PM1236765966 |e 910100PM1236765966 |k 0/910000/ |k 1/910000/910100/ |p 8 | ||
| 999 | |a KXP-PPN1504678710 |e 2847345884 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"part":{"year":"2014","extent":"1","issue":"21","volume":"124","text":"124(2014,21) Artikel-Nr. 74038, 1 S."},"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisher":"American Society of Hematology ; Saunders ; HighWire Press","publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif.","dateIssuedKey":"1946","dateIssuedDisp":"1946-"}],"language":["eng"],"note":["Gesehen am 21.04.2023"],"disp":"Addition of Rituximab to BEACOPP(escalated) to improve the outcome of early interim PET positive advanced stage Hodgkin lymphoma patients second planned interim analysis of the HD18 studyBlood","id":{"issn":["1528-0020"],"zdb":["1468538-3"],"eki":["266886647"]},"title":[{"subtitle":"journal of the American Society of Hematology","title":"Blood","title_sort":"Blood"}],"corporate":[{"roleDisplay":"Herausgebendes Organ","role":"isb","display":"American Society of Hematology"}],"titleAlt":[{"title":"Blood online"}],"pubHistory":["1.1946 -"],"recId":"266886647"}],"person":[{"family":"Borchmann","role":"oth","display":"Borchmann, Peter","given":"Peter"},{"family":"Meißner","given":"Julia","display":"Meißner, Julia","role":"oth"}],"name":{"displayForm":["Peter Borchmann, Heinz Haverkamp, Andreas Lohri, Stefanie Kreissl, Richard Greil, Jana Markova, Michaela Feuring-Buske, Julia Meissner, Ulrich Dührsen, Nicole Engel, Ulrich Keller, Georg Maschmeyer, Markus Dietlein, Carsten Kobe, Michael Fuchs, Volker Diehl, Andreas Engert"]},"physDesc":[{"extent":"1 S."}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"2014"}],"note":["Gesehen am30.06.2015"],"id":{"eki":["1504678710"]},"title":[{"title_sort":"Addition of Rituximab to BEACOPP(escalated) to improve the outcome of early interim PET positive advanced stage Hodgkin lymphoma patients","title":"Addition of Rituximab to BEACOPP(escalated) to improve the outcome of early interim PET positive advanced stage Hodgkin lymphoma patients","subtitle":"second planned interim analysis of the HD18 study"}],"recId":"1504678710"} | ||
| SRT | |a ADDITIONOF2014 | ||